Related Experiment Videos
[Single-lung transplantation for end-stage emphysema].
Jing-yu Chen1, Ming-feng Zheng, Yi-jun He
1Department of Thoracic Surgery, Wuxi Fifth People's Hospital, Wuxi 214073, China.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]
|August 5, 2003
Summary
Single-lung transplantation effectively improves pulmonary function in patients with end-stage emphysema. This case study details the operative technique, patient selection, and perioperative management for successful outcomes.
Area of Science:
- Pulmonary Medicine
- Thoracic Surgery
- Transplant Surgery
Background:
- End-stage emphysema significantly impairs quality of life and necessitates advanced treatment options.
- Lung transplantation is a viable, albeit complex, therapeutic strategy for select patients.
Observation:
- A 56-year-old patient with end-stage emphysema underwent a left-lung transplantation without cardiopulmonary bypass.
- The procedure utilized a standard surgical technique with donor lung perfusion via LPD solution, achieving a cold ischemic time of 260 minutes.
Findings:
- The patient successfully weaned from mechanical ventilation at 93 hours post-operation.
- Post-operative acute rejection on day nine was effectively managed with intravenous methylprednisolone.
- Significant improvement in lung function was observed, leading to hospital discharge on day 47.
Implications:
- Single-lung transplantation demonstrates efficacy in achieving long-term pulmonary function improvement for end-stage emphysema.
- This case highlights the importance of meticulous operative technique, careful patient selection, and comprehensive perioperative management.
- Further research into optimizing single-lung transplant protocols for emphysema patients is warranted.